Literature DB >> 3478100

Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.

N Tachibana1, S C Raimondi, S J Lauer, P Sartain, L W Dow.   

Abstract

Children with Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL) have a poorer prognosis than do most pediatric patients with ALL. Because of this poor prognosis and the presence of the Ph chromosome, we have asked whether or not Ph + ALL involves a multipotential stem cell. We cultured hematopoietic progenitors from two children with Ph+ ALL and examined individual BFU-E and CFU-GM colonies for the Ph chromosome. We studied cells from two patients after 18 to 34 months of first complete clinical remission; direct cytogenetic analyses showed 26% and 13% Ph+ metaphases in these patients' marrow cells. BFU-E colonies were obtained from light density marrow cells cultured in methylcellulose supplemented with erythropoietin and CFU-GM colonies from agar or methylcellulose cultures stimulated with leukocyte feeder layers. Fifty-seven G-banded metaphases were recovered from 33 colonies. Ten metaphases from seven colonies were Ph+. Ph+ metaphases were found in three of 12 and three of five BFU-E colonies from the two patients. One of 16 CFU-GM colonies from one patient had the Ph+ chromosome; analyzable metaphases were not obtained from CFU-GM of the other patient. No colonies contained both Ph+ and Ph- cells. These results indicate that Ph+ ALL with persistence of Ph+ cells in remission involves a multipotential stem cell for erythroid and granulocyte/macrophage as well as lymphoid lineages. Multipotential stem cell involvement in the pathogenesis of some childhood Ph+ ALL suggests similarities to Ph+ chronic myelocytic leukemia and may contribute to the poor prognosis of these patients.

Entities:  

Mesh:

Year:  1987        PMID: 3478100

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Molecular analysis of Philadelphia chromosome positive leukaemias.

Authors:  B D Young
Journal:  Br J Cancer Suppl       Date:  1988-12

2.  A novel in vitro assay for murine haematopoietic stem cells.

Authors:  L Eckmann; M Freshney; E G Wright; A Sproul; N Wilkie; I B Pragnell
Journal:  Br J Cancer Suppl       Date:  1988-12

3.  Clonal analysis of childhood acute lymphoblastic leukemia with "cytogenetically independent" cell populations.

Authors:  C H Pui; W H Raskind; G R Kitchingman; S C Raimondi; F G Behm; S B Murphy; W M Crist; P J Fialkow; D L Williams
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

4.  Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

Authors:  J McLaughlin; E Chianese; O N Witte
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

5.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

6.  Stem cell origins of leukaemia and curability.

Authors:  M F Greaves
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

7.  Unusual T-lymphoblastic blast phase of chronic myelogenous leukemia.

Authors:  Jie Xu; Shaoying Li
Journal:  Case Rep Hematol       Date:  2014-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.